“FORMULATION AND EVALUATION OF SUSTAINED RELEASE …

In a subgroup of black patients (11% of the study population), there was a trend towards less of a SBP reduction by ABPM compared to white patients. Side effects were similar between treatment groups with headache, dizziness, and dyslipidemia the most frequently occurring adverse effects. ................
................